Cardiovascular magnetic resonance of cardiomyopathies

Current Cardiology Reports

Volumn 11, Issue 1, 2009, Pages 61-69

  Alpendurada, Francisco ^a   O'Hanlon, Rory ^a   Prasad, Sanjay K ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOMYOPATHY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION AND FORECASTING; REPRODUCIBILITY; REVIEW;

CARDIOMYOPATHIES; HUMANS; MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS;

EID: 63249129506     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-009-0010-3     Document Type: Article

References (47)

1. Aherne T, Tscholakoff D, Finkbeiner W, et al.: Magnetic resonance imaging of cardiac transplants: the evaluation of rejection of cardiac allografts with and without immunosuppression. Circulation 1986, 74:145-156. (Pubitemid 16092935)
2. Kim RJ, Fieno DS, Parrish TB, et al.: Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999, 100:1992-2002. (Pubitemid 29529292)
3. Mahrholdt H, Goedecke C, Wagner A, et al.: Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004, 109:1250-1258. (Pubitemid 38379570)
4. Vogelsberg H, Mahrholdt H, Deluigi CC, et al.: Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol 2008, 51:1022-1030. Largest series on diagnosis of cardiac amyloidosis by CMR. (Pubitemid 351318125)
5. McCrohon JA, Moon JC, Prasad SK, et al.: Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium enhanced cardiovascular magnetic resonance. Circulation 2003, 108:54-59. (Pubitemid 36859020)
6. Soriano CJ, Ridocci F, Estornell J, et al.: Late gadoliniumenhanced cardiovascular magnetic resonance identifies patients with standardized definition of ischemic cardiomyopathy: a single centre experience. Int J Cardiol 2007, 116:167-173.
7. Assomull RG, Prasad SK, Lyne J, et al.: Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006, 48:1977-1985. First article demonstrating LGE as a predictor of major adverse outcome events in patients with cardiomyopathy. (Pubitemid 44738448)
8. Wu KC, Weiss RG, Thiemann DR, et al.: Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol 2008, 51:2414-2421. (Pubitemid 351826874)
9. Nazarian S, Bluemke DA, Lardo AC, et al.: Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation 2005, 112:2821-2825. (Pubitemid 41641676)
10. Assomull RG, Lyne JC, Keenan N, et al.: The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. Eur Heart J 2007, 28:1242-1249. (Pubitemid 47343853)
11. Mahrholdt H, Wagner A, Deluigi CC, et al.: Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 2006, 114:1581-1590. Seminal article on the evaluation of myocarditis by CMR. (Pubitemid 44547428)
12. Moon JC, Fisher NG, McKenna WJ, Pennell DJ: Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with nondiagnostic echocardiography. Heart 2004, 90:645-649. (Pubitemid 38668538)
13. Rickers C, Wilke NM, Jerosch-Herold M, et al.: Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 2005, 112:855-861. (Pubitemid 41170072)
14. Moon JC, McKenna WJ, McCrohon JA, et al.: Towa r d clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 2003, 41:1561-1567. (Pubitemid 36543376)
15. Adabag AS, Maron BJ, Appelbaum E, et al.: Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 2008, 51:1369-1374. LGE as a predictor of ventricular tachyarrhythmias in HCM. (Pubitemid 351443083)
16. Petersen SE, Jerosch-Herold M, Hudsmith LE, et al.: Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging. Circulation 2007, 115:2418-2425. (Pubitemid 46717964)
17. Olivotto I, Maron MS, Autore C, et al.: Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 2008, 52:559-566.
18. Maron MS, Hauser TH, Dubrow E, et al.: Right ventricular involvement in hypertrophic cardiomyopathy. Am J Cardiol 2007, 100:1293-1298. (Pubitemid 47500158)
19. Abdel-Aty H, Cocker M, Strohm O, et al.: Abnormalities in T2-weighted cardiovascular magnetic resonance images of hypertrophic cardiomyopathy: regional distribution and relation to late gadolinium enhancement and severity of hypertrophy. J Magn Reson Imaging 2008, 28:242-245. (Pubitemid 351956489)
20. McKenna WJ, Thiene G, Nava A, et al.: Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy: task force of the working group myocardial and pericardial disease of the European Society of Cardiology and of the Scientific Council on cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 1994, 71:215-218.
21. Sen-Chowdhry S, Prasad SK, Syrris P, et al.: Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited: comparison with task force criteria and genotype. J Am Coll Cardiol 2006, 48:2132-2140. Seminal article on the diagnostic accuracy of CMR in ARVC. (Pubitemid 44738443)
22. Bluemke DA, Krupinski EA, Ovitt T, et al.: MR imaging of arrhythmogenic right ventricular cardiomyopathy: morphologic findings and interobserver reliability. Cardiology 2003, 99:153-162. (Pubitemid 36736958)
23. Tandri H, Saranathan M, Rodriguez ER, et al.: Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol 2005, 45:98-103. (Pubitemid 40052034)
24. Kohli SK, Pantazis AA, Shah JS, et al.: Diagnosis of leftventricular non-compaction in patients with left-ventricular systolic dysfunction: time for a reappraisal of diagnostic criteria? Eur Heart J 2008, 29:89-95.
25. Petersen SE, Selvanayagam JB, Wiesmann F, et al.: Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol 2005, 46:101-105. (Pubitemid 40905136)
26. Nef HM, Möllmann H, Elsässer A: Ta ko-tsubocardiomyopathy (apical ballooning). Heart 2007, 93:1309-1315.
27. Abdel-Aty H, Cocker M, Friedrich MG: Myocardial edema is a feature of Tako-Tsubo cardiomyopathy and is related to the severity of systolic dysfunction: Insights from T2-weighted cardiovascular magnetic resonance. Int J Cardiol 2007 Dec. 15 (Epub ahead of print).
28. Silva MC, Meira ZM, Gurgel Giannetti J, et al.: Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy. J Am Coll Cardiol 2007, 49:1874-1879. (Pubitemid 46661108)
29. Iannuzzi MC, Rybicki BA, Teirstein AS: Sarcoidosis. N Engl J Med 2007, 357:2153-2165.
30. Smedema JP, Snoep G, van Kroonenburgh MP, et al.: Evaluation of the accuracy of gadolinium-enhanced CMR in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 2005, 45:1683-1690. (Pubitemid 40704507)
31. Shah KB, Inoue Y, Mehra MR: Amyloidosis and the heart: a comprehensive review. Arch Intern Med 2006, 166:1805-1813. (Pubitemid 44455160)
32. Maceira AM, Joshi J, Prasad SK, et al.: Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005, 111:186-193. (Pubitemid 40139730)
33. Sachdev B, Takenaka T, Teraguchi H, et al.: Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation 2002, 105:1407-1411. (Pubitemid 34263268)
34. Moon JC, Sachdev B, Elkington AG, et al.: Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J 2003, 24:2151-2155. (Pubitemid 37486535)
35. Hughes DA, Elliott PM, Shah J, et al.: Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa. Heart 2008, 94:153-158. (Pubitemid 351211719)
36. World Health Organization: The World Health Report 2002. Annexes and Tables. Geneva: World Health Organization; 2002:192.
37. Rochitte CE, Oliviera PF, Andrade JM: Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of disease severity. J Am Coll Cardiol 2005, 46:1553-1558. (Pubitemid 41446195)
38. Cury RC, Abbara S, Sandoval LJ, et al.: Images in cardiovascular medicine. Visualization of endomyocardial fibrosis by delayed-enhancement magnetic resonance imaging. Circulation 2005, 111:e115-e117.
39. Modell B, Khan M, Darlison M: Survival in beta thalassaemia major in the UK: Data from the UK Thalassaemia Register. Lancet 2000, 355:2051-2052. (Pubitemid 30339248)
40. *) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001, 21:2171-2179. (Pubitemid 33139463)
41. Tanner MA, Galanello R, Dessi C, et al.: Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with severe left ventricular dysfunction. J Cardiovasc Magn Reson 2008, 10:12. Use of CMR in the management of thalassemia major patients.
42. * cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2008 (in press).
43. Kramer CM, Barkhausen J, Flamm SD, et al.: Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. J Cardiovasc Magn Reson 2008, 10:35.
44. Francis JM, Pennell DJ: Treatment of claustrophobia for cardiovascular magnetic resonance: use and effectiveness of mild sedation. J Cardiovasc Magn Reson 2000, 2:139-141. (Pubitemid 30346844)
45. Nazarian S, Roguin A, Zviman MM, et al.: Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla. Circulation 2006, 114:1277-1284. (Pubitemid 44402053)
46. Dill T: Contraindications to magnetic resonance imaging: non-invasive imaging. Heart 2008, 94:943-948. (Pubitemid 351914712)
47. Levine GN, Gomes AS, Arai AE, et al.: Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention. Circulation 2007, 116:2878-2891. (Pubitemid 350291228)